V-ATPase inhibition overcomes trastuzumab resistance in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

V-ATPase inhibition overcomes trastuzumab resistance in breast cancer

Published:2013-09-05 Issue:1 Volume:8 Page:9-19
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

von Schwarzenberg Karin,Lajtos Tamás,Simon Làszló,Müller Rolf,Vereb György,Vollmar Angelika M.

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference41 articles.

1. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin;Austin;Mol. Biol. Cell.,2004

2. Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, nocodazole, and low temperature;Baravalle;Cell. Tissue Res.,2005

3. Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor;Barok;Cancer Lett.,2008

4. Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance;Barok;Mol. Cancer Ther.,2007

5. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer;Chandarlapaty;Clin. Cancer Res.,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts;ACS Pharmacology & Translational Science;2024-09-12

2. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer;Mini-Reviews in Medicinal Chemistry;2024-08

3. Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs;Journal of Controlled Release;2023-03

4. The V-ATPases in cancer and cell death;Cancer Gene Therapy;2022-05-03

5. Lysosomal TRPML1 regulates mitochondrial function in hepatocellular carcinoma cells;Journal of Cell Science;2022-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3